Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
pmid:
Utani A and Hattori Y A reactive acrosyringeal proliferation in a patient with ectodermal dysplasia: eccrine syringofibroadenoma-like lesion. 1999 J. Dermatol. pmid:10063211
Ozawa A et al. Treatments of generalized pustular psoriasis: a multicenter study in Japan. 1999 J. Dermatol. pmid:10209919
Sjögren F et al. Expression and function of beta 2 integrin CD11B/CD18 on leukocytes from patients with psoriasis. 1999 Acta Derm. Venereol. pmid:10228626
Young KJ and Lee PN Intervention studies on cancer. 1999 Eur. J. Cancer Prev. pmid:10335455
Budzyńska B et al. Morphometric measurements of several parameters of rat epidermis after a 28-day period of vitamin A derivative (etretinate) administration and a 28-day pause. 1999 Folia Histochem. Cytobiol. pmid:10353006
Roth AD et al. High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas. 1999 Acta Oncol pmid:10427950
Khatri ML et al. Xeroderma pigmentosum in Libya. 1999 Int. J. Dermatol. pmid:10440281
Katz HI et al. Acitretin in psoriasis: an overview of adverse effects. 1999 J. Am. Acad. Dermatol. pmid:10459140
Chaudhuri BN et al. Structures of cellular retinoic acid binding proteins I and II in complex with synthetic retinoids. 1999 Acta Crystallogr. D Biol. Crystallogr. pmid:10531482
Giannetti A et al. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis. 1999 J Eur Acad Dermatol Venereol pmid:10568486
Orfanos CE Treatment of psoriasis with retinoids: present status. 1999 Cutis pmid:10582161
Fujii K et al. Etretinate therapy for papuloerythroderma. 1999 Eur J Dermatol pmid:10586126
Vaccaro M et al. Subcorneal pustular dermatosis and IgA lambda myeloma: a uncommon association but probably not coincidental. 1999 Eur J Dermatol pmid:10586134
Brodell RT and Williams L A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. 1999 Postgrad Med pmid:10608962
Koreeda T et al. Inhibitory effect of retinoid on esophageal carcinogenesis in rats induced by N-nitroso-N-methylbutylamine in relation to cellular retinoic acid-binding protein. 1999 Sep-Oct Anticancer Res. pmid:10628365
Koide D et al. Computerized reminders to monitor liver function to improve the use of etretinate. 2000 Int J Med Inform pmid:10708252
Hotard RS et al. Sex-specific differences in the treatment of severe psoriasis. 2000 J. Am. Acad. Dermatol. pmid:10727307
Siragusa M et al. A new family with Papillon-Lefèvre syndrome: effectiveness of etretinate treatment. 2000 Cutis pmid:10738634
Pejaver RK et al. Etretinate in the management of harlequin siblings. 1998 Mar-Apr Indian J Pediatr pmid:10771980